The nona-mer peptide AE105 has been described as a ligand with nano-molar affinity for uPAR and has served as a platform in our group and by others, to develop preclinical AE105-based molecular conjugations for tumor-specific PET imaging and therapy [16–20]. This evidence concerns the gene PLAUR and neoplasm.